NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

TB & Outbreaks Week

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB & Outbreaks Week

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Bacillus Calmette-Guerin Vaccines



Scientists at Pasteur Institute of Iran release new data on Bacillus calmette-guerin vaccines



March 17th, 2009

A report, 'Comparison of QuantiFERON TB-G-test to TST for detecting latent tuberculosis infection in a high-incidence area containing BCG-vaccinated population,' is newly published data in Journal of Evaluation In Clinical Practice. According to recent research from Iran, "Until recently, the only tool for detection of latent tuberculosis infection (LTBI) was the tuberculin skin test (TST). QuantiFERON-TB Gold In-Tube test (QFT) is a promising in vitro diagnostic test for LTBI that has potential advantages over the TST."

"In this study we aimed to compare QFT with TST for diagnosis of LTBI. A total of 186 BCG-vaccinated subjects enrolled in study. They underwent...


Source: TB & Outbreaks Week (2009-03-17)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login